[1]
Wright, I., Civitarese, A. and Baverstock, R. 2016. The use of intra-detrusor onabotulinumtoxinA in patients with myasthenia gravis. Canadian Urological Association Journal. 10, 5-6 (May 2016), E184–5. DOI:https://doi.org/10.5489/cuaj.3678.